These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30866680)

  • 1. Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction.
    Veenis JF; Brunner-La Rocca HP; Linssen GC; Geerlings PR; Van Gent MW; Aksoy I; Oosterom L; Moons AH; Hoes AW; Brugts JJ;
    Eur J Prev Cardiol; 2019 Sep; 26(13):1399-1407. PubMed ID: 30866680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
    Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.
    Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK
    Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry.
    Chang HY; Wang CC; Wei J; Chang CY; Chuang YC; Huang CL; Chong E; Lin JL; Mar GY; Chan KC; Kuo JY; Wang JH; Chen ZC; Tseng WK; Cherng WJ; Yin WH
    J Chin Med Assoc; 2017 Dec; 80(12):750-757. PubMed ID: 29033112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
    Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
    Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.
    Chin KL; Skiba M; Tonkin A; Reid CM; Liew D; Krum H; Hopper I
    Heart Fail Rev; 2016 Nov; 21(6):675-697. PubMed ID: 27465132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of guideline-based cardiovascular medications and their respective doses in heart failure patients in Oman.
    Hanbali DA; Hashmi KA; Za'abi MA; Al-Zakwani I
    Int J Clin Pharm; 2021 Aug; 43(4):878-883. PubMed ID: 33140296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012.
    Thorvaldsen T; Benson L; Dahlström U; Edner M; Lund LH
    Eur J Heart Fail; 2016 May; 18(5):503-11. PubMed ID: 26869252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
    Greene SJ; Butler J; Albert NM; DeVore AD; Sharma PP; Duffy CI; Hill CL; McCague K; Mi X; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Am Coll Cardiol; 2018 Jul; 72(4):351-366. PubMed ID: 30025570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata.
    Stolfo D; Lund LH; Becher PM; Orsini N; Thorvaldsen T; Benson L; Hage C; Dahlström U; Sinagra G; Savarese G
    Eur J Heart Fail; 2022 Jun; 24(6):1047-1062. PubMed ID: 35278267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Heart Failure Patient with CKD.
    Banerjee D; Rosano G; Herzog CA
    Clin J Am Soc Nephrol; 2021 Jul; 16(7):1131-1139. PubMed ID: 33495289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study.
    Driscoll A; Dinh D; Wong J; Hopper I; Mariani J; Zimmet H; Brennan A; Lefkovits J; Carruthers H; Reid CM
    Heart Lung Circ; 2020 Dec; 29(12):1782-1789. PubMed ID: 32646638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.
    Kruik-Kollöffel WJ; Linssen GCM; Kruik HJ; Movig KLL; Heintjes EM; van der Palen J
    Heart Fail Rev; 2019 Jul; 24(4):499-510. PubMed ID: 30848404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Optimization of Medical Treatment on Long-Term Survival of Patients With Heart Failure After Implantable Cardioverter Defibrillator and Cardiac Resynchronization Device Implantation (from the French National EGB Database).
    Massoullié G; Chouki C; Mulliez A; Rossignol P; Ploux S; Pereira B; Reuillard A; Jean F; Andronache M; Eschalier A; Motreff P; Clerfond G; Bordachar P; Authier N; Eschalier R
    Am J Cardiol; 2018 Mar; 121(6):725-730. PubMed ID: 29402420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
    Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
    Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION Trial.
    Bristow MR; Saxon LA; Feldman AM; Mei C; Anderson SA; DeMets DL
    JACC Heart Fail; 2016 Jul; 4(7):521-535. PubMed ID: 27289408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sex-specific target dose in chronic heart failure patients with reduced ejection fraction.
    Veenis JF; Rocca HB; Linssen GCM; Erol-Yilmaz A; Pronk ACB; Engelen DJM; van Tooren RM; Koornstra-Wortel HJJ; de Boer RA; van der Meer P; Hoes AW; Brugts JJ;
    Eur J Prev Cardiol; 2021 Aug; 28(9):957-965. PubMed ID: 34402878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.